These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 2543272)

  • 21. Excitatory amino acid receptors and disease.
    Meldrum BS
    Curr Opin Neurol Neurosurg; 1992 Aug; 5(4):508-13. PubMed ID: 1325224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of excitatory amino acid binding sites in the chick optic tectum.
    Ramirez G; Gómez-Barriocanal J; Escudero E; Fernández-Quero S; Barat A
    Adv Biochem Psychopharmacol; 1981; 29():467-74. PubMed ID: 6266228
    [No Abstract]   [Full Text] [Related]  

  • 23. Physiology and pathophysiology of excitatory amino acid neurotransmitter systems in relation to Alzheimer's disease.
    Foster AC
    Adv Neurol; 1990; 51():97-102. PubMed ID: 2152999
    [No Abstract]   [Full Text] [Related]  

  • 24. Perspectives on the discovery of central monoaminergic neurotransmission.
    Carlsson A
    Annu Rev Neurosci; 1987; 10():19-40. PubMed ID: 3032064
    [No Abstract]   [Full Text] [Related]  

  • 25. GABA and glycine receptors in CNS cultures: autoradiographic binding and electrophysiological studies.
    Hösli L; Hösli E; Andrès PF; Landolt H
    Adv Biochem Psychopharmacol; 1981; 29():437-43. PubMed ID: 6266226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The function of taurine in the central nervous system.
    Rassin DK
    Adv Biochem Psychopharmacol; 1981; 29():127-34. PubMed ID: 6114619
    [No Abstract]   [Full Text] [Related]  

  • 27. Les agents provocateurs: a series on the pharmacology of excitatory amino acids.
    Lodge D; Collingridge G
    Trends Pharmacol Sci; 1990 Jan; 11(1):22-4. PubMed ID: 2155494
    [No Abstract]   [Full Text] [Related]  

  • 28. Excitatory amino acid receptor stimulation: involvement of cyclic GMP?
    Foster GA; Roberts PJ
    Adv Biochem Psychopharmacol; 1983; 37():175-85. PubMed ID: 6314756
    [No Abstract]   [Full Text] [Related]  

  • 29. Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
    Schoepp DD; Johnson BG; Smith EC; McQuaid LA
    Mol Pharmacol; 1990 Aug; 38(2):222-8. PubMed ID: 2166902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of excitatory amino acid transmitters.
    Watkins JC
    Adv Biochem Psychopharmacol; 1981; 29():205-12. PubMed ID: 6114621
    [No Abstract]   [Full Text] [Related]  

  • 31. Central hypotensive activity of ketanserin in cats.
    van Zwieten PA; Mathy MJ; Boddeke HW; Doods HN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S54-8. PubMed ID: 2446072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation between the excitatory and "excitotoxic" effects of quinolinic acid analogs on the striatal cholinergic interneuron.
    Lehmann J; Ferkany JW; Schaeffer P; Coyle JT
    J Pharmacol Exp Ther; 1985 Mar; 232(3):873-82. PubMed ID: 2983071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal receptor sites for kainic acid: correlations with neurotoxicity.
    Coyle JT; Zaczek R; Slevin J; Collins J
    Adv Biochem Psychopharmacol; 1981; 27():337-46. PubMed ID: 6255764
    [No Abstract]   [Full Text] [Related]  

  • 34. Excitatory amino acids toxicity in cerebellar granule cells in primary culture.
    Novelli A; Kispert J; Reilly A; Zitko V
    Can Dis Wkly Rep; 1990 Sep; 16 Suppl 1E():83-8; discussion 88-9. PubMed ID: 1966281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The receptors involved in the excitatory effects of kynurenines].
    Lapin IP; Ryzhov IV
    Farmakol Toksikol; 1989; 52(1):98-104. PubMed ID: 2540028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of long-term neuroleptic administration on CNS receptors plasticity].
    Allikmets LKh; Zharkovskiĭ AM; Nurk AM; Vasar EE; Maĭmets MO
    Vestn Akad Med Nauk SSSR; 1984; (11):37-42. PubMed ID: 6152099
    [No Abstract]   [Full Text] [Related]  

  • 37. Properties of two classes of rat brain acidic amino acid receptors induced by distinct mRNA populations in Xenopus oocytes.
    Fong TM; Davidson N; Lester HA
    Synapse; 1988; 2(6):657-65. PubMed ID: 2905539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.
    Bridges RJ; Esslinger CS
    Pharmacol Ther; 2005 Sep; 107(3):271-85. PubMed ID: 16112332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of excitatory amino acid receptors reduces thymidine incorporation and cell proliferation rate in primary cultures of astrocytes.
    Condorelli DF; Ingrao F; Magri G; Bruno V; Nicoletti F; Avola R
    Glia; 1989; 2(1):67-9. PubMed ID: 2565288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system.
    Simmen U; Burkard W; Berger K; Schaffner W; Lundstrom K
    J Recept Signal Transduct Res; 1999; 19(1-4):59-74. PubMed ID: 10071750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.